Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00564330
Other study ID # D9612L00118
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received November 26, 2007
Last updated August 25, 2014
Start date November 2007
Est. completion date May 2008

Study information

Verified date August 2014
Source Brain-Gut Research Group
Contact n/a
Is FDA regulated No
Health authority Switzerland: Ethikkommission
Study type Interventional

Clinical Trial Summary

Dental erosions in 30 male and female patients with proven abnormal gastrooesophageal reflux will be assessed clinically and using a novel optical coherence tomography (OCT) laser technique before and after double-blind randomization to antisecretory treatment with esomeprazole 20mg or placebo bid for 3 weeks.

The primary objective is to quantify tooth substance loss as well as changes in optical reflectance and scattering of dental hard tissues with and without acid inhibition.

Secondary objectives are:

To compare standardised visual scoring with OCT quantification of reflux damage at the different time points on different teeth.

To assess sex differences in OCT- quantified dental tissue loss.


Description:

Dental erosions in 30 male and female patients with proven abnormal gastrooesophageal reflux will be assessed clinically and using a novel optical coherence tomography (OCT) laser technique before and after double-blind randomization to antisecretory treatment with esomeprazole 20mg or placebo bid for 3 weeks.

The primary objective is to quantify tooth substance loss as well as changes in optical reflectance and scattering of dental hard tissues with and without acid inhibition.

Secondary objectives are:

To compare standardised visual scoring with OCT quantification of reflux damage at the different time points on different teeth.

To assess sex differences in OCT- quantified dental tissue loss


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date May 2008
Est. primary completion date April 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Dental erosions with Lussi score greater than 1, diagnosed by dentist

2. Provision of informed consent

3. Male or female aged 18 or above years

4. GORD defined by time with pH<4 greater than 3.5% during 24 hours demonstrated by 24h-hour pH-metry in the last 6 months before the start of the study

Exclusion Criteria:

1. Significant illness within 2 weeks of study begin as judged by investigator.

2. Established or suspected non-reflux causes for dental erosions.

3. Inadequate exclusion of other causes for dental erosions (diet, psychiatric, bruxism, salivary abnormalities, vomiting, etc).

4. Inability or unwillingness to give informed consent.

5. Inability to attend all study.

6. New dental treatment (including dental products) may not be begun from 2 weeks before study begin until the end of the study, except usual dental hygiene with usual toothpaste.

7. Allergy to or other contraindication for treatment with esomeprazole.

8. Use of proton pump inhibitors in 2 weeks or other acid inhibitory drugs in 3 days before study inclusion.

9. Substantial change or planned change in dietary pattern, esp. diets within 2 weeks of study start and for the duration of the entire study.

10. Change or planned change in normal medication or use of herbal, mineral, vitamin preparations within 2 weeks of study start and until the end of the study.

11. Congenital dental defects.

12. Ongoing pregnancy or breast-feeding.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Drug:
Esomeprazole
20mg bid
Placebo
Placebo bid

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Brain-Gut Research Group Beckman Laser Institute University of California Irvine

Outcome

Type Measure Description Time frame Safety issue
Primary Dental erosions by OCT 3 weeks No
Secondary OCT parameters 3 weeks No
See also
  Status Clinical Trial Phase
Completed NCT02548156 - Intra Oral Kinetics of Fluoride Containing Dentifrices N/A
Completed NCT02533466 - In Vivo Investigation of Initial Stages of Enamel Erosion N/A
Completed NCT04586322 - Association Between Erosive Tooth Wear Progression and Dietary Risk Factors.
Active, not recruiting NCT03112278 - Clinical Evaluation of Ultrathin Occlusal Veneers for the Treatment of Severe Dental Erosion N/A
Completed NCT01622920 - Preliminary Clinical Study of Ultrasound to Measure Enamel Thickness Phase 1
Completed NCT03296072 - In Situ Erosion Study to Investigate the Effectiveness of an Experimental Toothpaste Phase 3
Completed NCT03101943 - Preventing Early Childhood Obesity, Part 1: Family Spirit Nurture, 3-9 Months N/A
Completed NCT03515902 - The Effects of Mouthguard and Desensitizing Toothpaste in Reducing Dental Hypersensitivity N/A
Completed NCT05146557 - Associations Between Obesity, Dental Caries, Erosive Tooth Wear and Periodontal Disease in Adolescents: A Case Control-study
Completed NCT02676219 - Pilot Study Utilising an Impression Technique to Capture in Vivo Images of Teeth N/A
Completed NCT03577834 - The Effect of Vinegar Consumption on Visceral Fat and Blood Glucose Concentration N/A
Completed NCT06242444 - An Erosion Study to Investigate the Efficacy of an Experimental Dentifrice to Remineralize Enamel N/A
Completed NCT01128972 - Evaluation of a Test Mouthwash and Dentifrice Regimen in an In-situ Model of Dental Erosion Phase 2
Completed NCT06136754 - Investigate a Varnish to Protect From Erosive Toothwear Phase 3